GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
JULY 31, 2023
GSK has won the first FDA approval for an immunotherapy to treat certain patients with newly diagnosed endometrial cancer. But the industry-first go-ahead is tempered with a label limitation. | But the industry-first go-ahead is tempered with a label limitation.
242 
Let's personalize your content